(Q46420426)

English

Predominant inhibition of interleukin-6 synthesis in patient-specific endothelial cells by mTOR inhibitors below a concentration range where cell proliferation is affected and mitotic arrest takes place

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808580

Predominant inhibition of interleukin-6 synthesis in patient-specific endothelial cells by mTOR inhibitors below a concentration range where cell proliferation is affected and mitotic arrest takes place (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808580

author name string

Lehle K

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808580

Birnbaum DE

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808580

Preuner JG

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808580

language of work or name

0 references

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808580

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808580

37

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808580

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808580

159-161

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808580

Influence of a novel rapamycin analogon SDZ RAD on endothelial tissue factor and adhesion molecule expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.140

7 January 2021

Everolimus: a proliferation signal inhibitor targeting primary causes of allograft dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.140

7 January 2021

Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.140

7 January 2021

Effect of SDZ RAD on transplant arteriosclerosis in the rat aortic model

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.140

7 January 2021

Expression of adhesion molecules and cytokines in vitro by endothelial cells seeded on various polymer surfaces coated with titaniumcarboxonitride

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.140

7 January 2021

Oral everolimus inhibits in-stent neointimal growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.140

7 January 2021

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.140

7 January 2021

FK506 suppresses the mitogen-induced increase in lymphocyte adhesiveness to endothelial cells, but does not affect endothelial cell activation in response to inflammatory stimuli

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.140

7 January 2021

Association of glucocorticoids and cyclosporin A or rapamycin prevents E-selectin and IL-8 expression during LPS- and TNFalpha-mediated endothelial cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.140

7 January 2021

Interleukin-6 and cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.140

7 January 2021

Rapamycin effects transcriptional programs in smooth muscle cells controlling proliferative and inflammatory properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.140

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2004.12.140

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808580

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15808580

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46420426&oldid=2110500104"